Environmental groups opposed to Royal Dutch Shell's (RDS.A, RDS.B) exploration plans in the Alaskan Arctic file a lawsuit challenging the ability of the Port of Seattle to lease out one of its terminals to serve as a home base for Shell's drilling fleet.

The Sierra Club and others file the suit in a Washington state court, arguing the drilling operation was substantially different from the terminal's prior use, meaning an environmental review had to be done under state law.

The complaint against the port and Shell contractor Foss Maritime also alleges that officials reached the arrangement without public disclosure and that the fleet could pollute the area's water.

Omnicom Media Group (NYSE:OMC) enters into an upfront deal covering about $50M in advertising with National CineMedia (NASDAQ:NCMI), which places ads in front of moviegoers and on their mobiles nationwide.

National CineMedia -- owned by America's biggest theater circuits, Regal, AMC and Cinemark along with smaller partners -- says it reaches more than 710M consumers a year.

The move is another step in Omnicom's premium-video focus, which has increasingly entailed cinema inventory buys. It's NCM's first ever agency upfront.

Omnicom shares were 0.7% lower today to $79.94, after touching their 52-week high of $80.98 yesterday.

Putting a number on the dismantling of Royal Bank of Scotland's (NYSE:RBS) investment bank, the FT reports the bank has set a target of cutting up to four out of five jobs in the unit by 2019 - a full 14K positions. A large proportion of those will be in the U.S. and Asia.

"I am not a very patient person," said Barclays (NYSE:BCS) CEO Antony Jenkins after his bank reported a loss for 2014. "We won't hesitate to optimize the capital allocated to the investment bank." There have been long-running rumors Barclays might spin off or sell its investment bank, as analysts say it's better positioned to do so than RBS, especially as regulators are forcing it to split its U.K. and U.S. operations into separately funded entities.

In a regulatory filing, Arena Pharmaceuticals (NASDAQ:ARNA) discloses that it expects commercial partner Eisai to refile the Marketing Authorization Application (MAA) in Europe for its obesity drug Belviq (lorcaserin HCl) by the end of the latter's fiscal year ending March 31, 2016.

Arena originally submitted the Belviq MAA in March 2012. In January 2013 it received a Day 180 List of Outstanding Issues from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). The major objections preventing approval pertained to non-clinical and clinical issues including tumors in rats, valvuopathy and psychiatric events. CHMP requested that the benefit-risk balance of Belviq be further justified taking these issues into consideration. After a written response to the Day 180 List and an oral presentation to CHMP failed to assuage its concerns, the company withdrew the MAA in May 2013.

Textron's (NYSE:TXT) Bell Helicopter announces deals that could lead to the sale of more than 200 aircraft, as Air Methods (NASDAQ:AIRM) agrees to buy 200 Bell 407GXP helicopters for its core medical transport business, and Waypoint Leasing signs a tentative deal to buy 20 new 525 Relentless helicopters.

AIRM, which operates a fleet of more than 400 helicopters, will take delivery of the new Bell 407GXP for 10 years beginning next year; financial terms were not disclosed.

Ireland-based Waypoint would be one of the first customers for the new 525 Relentless, Bell's prime offering for the oil and gas market; the helicopter also is aimed at the search-and-rescue and firefighting markets.

The special distribution of $6.5M or $0.50 per share will be paid out monthly over the remainder of the year (a nickel per month). This represents a 32% premium over the normal monthly distributions.

Capitala (NASDAQ:CPTA) exited in late December its equity investment in Chef'n Corporation, receiving $3.7M, including $2.9M in cash and $800K in rollover preferred equity. The $2.7M realized gain in Q4 represented an IRR of 61%, and a 4.2 multiple on invested cash.

Today, the company sold 179,748 shares (30% of its stake) in Boot Barn (NYSE:BOOT) for $22.33 each. The realized gain on the sold shares is $3.3M, or a 78% IRR. Capitala still holds 420K shares at a cost basis of $4 each.